Acute Cholangitis: Evidence-Based Management

Pathophysiology & Background

Clinical Diagnosis

Tokyo Guidelines Severity Grading (TG18)

• Cardiovascular: hypotension requiring vasopressors
• Neurological: altered consciousness
• Respiratory: PaO2/FiO2 <300
• Renal: oliguria, creatinine >2.0 mg/dL
• Hepatic: PT-INR >1.5
• Hematologic: platelets <100,000/µL

Imaging

• Ultrasound (first-line): identifies biliary dilatation and gallstones, but only ~50% sensitive for CBD stones due to duodenal gas interference.
• CT: better for level of obstruction; 94% accuracy for choledocholithiasis when suspected.
• MRCP/EUS: near-ERCP sensitivity/specificity for CBD stones; used when clinical suspicion is not strong enough to justify immediate ERCP, and provides an anatomical roadmap.
• ERCP: diagnostic and therapeutic in one session - preferred when strong clinical suspicion of severe cholangitis. Do NOT use as a purely diagnostic tool given its complication profile.

Management: Severity-Stratified Approach

Step 1: All Patients - Immediate Resuscitation

• IV fluid resuscitation
• Correction of electrolytes and coagulopathy
• Analgesia
• Blood cultures before antibiotics
• Bile cultures at time of drainage

Step 2: Antibiotic Therapy (All Grades)

• Piperacillin-tazobactam or a fluoroquinolone (e.g., ciprofloxacin) - preferred over older ampicillin + aminoglycoside combinations (latter associated with gram-negative resistance and nephrotoxicity)
• Add anaerobic coverage (e.g., metronidazole) if prior bilioenteric surgery (hepatojejunostomy, Billroth II, choledochoduodenostomy)
• Be alert for ESBL-producing Enterobacteriaceae - carbapenem may be needed based on local resistance data

• Standard: 4-7 days after source control achieved
• If bacteremia present: 14 days (risk of endocarditis)
• A 2024 RCT (Srinu et al., PMID 37732816) in 120 patients with moderate-severe cholangitis found 4-day antibiotic courses were non-inferior to 8-day courses in clinical cure rates (78% vs 80%, p=0.82) after successful biliary drainage, with no difference in mortality or recurrence - suggesting shorter courses are appropriate once source control is achieved. Malignant etiology and hypotension at presentation were associated with lower cure rates.
• An older RCT (Maingot's Abdominal Operations) also found that 3-day courses may be sufficient in uncomplicated cases after drainage.

Step 3: Biliary Drainage - The Definitive Treatment

Drainage Modalities

• Transpapillary route; allows stone extraction, sphincterotomy, stent placement, or nasobiliary tube (NBT) placement simultaneously
• In severe/unstable patients: initial placement of biliary stent or NBT to decompress (palliative intent); definitive stone clearance deferred
• Key technique: aspirate infected bile under pressure before injecting contrast - repeated contrast injection into an obstructed system raises intrabiliary pressure and worsens cholangiovenous reflux/sepsis
• Delay >48h to ERCP is associated with higher costs and longer hospital stays; drainage within 24h predicts improved survival
• Plastic stent vs. NBT: both equally effective for initial drainage; plastic stent avoids patient discomfort from NBT

• Used when ERCP fails or anatomy is altered (post-surgical)
• Avoids percutaneous access morbidity; limited by availability of local expertise
• Effective rescue option after failed ERCP

• Used when ERCP and EUS-guided drainage fail or are unavailable
• Higher morbidity than endoscopic routes
• Particularly useful for hilar or intrahepatic obstruction

• Common bile duct exploration + T-tube placement
• Reserved when endoscopic and percutaneous approaches are unavailable or unsuccessful
• Definitive surgical treatment of the underlying cause (e.g., cholecystectomy) is deferred until:
  • Hemodynamic stability restored
  • Cholangitis resolved
  • Definitive diagnosis confirmed

Subsequent Definitive Management

• After cholangitis resolves, cholecystectomy is indicated in patients with gallstone disease to prevent recurrence - for mild disease, this can be performed before discharge; for severe disease, delayed until full recovery.
• Intraoperative cholangiography should be performed at cholecystectomy when choledocholithiasis is suspected.
• Definitive ERCP for complete stone clearance or stricture management follows once the patient is stable.

Summary Table

• Sabiston Textbook of Surgery (22nd ed.)
• Yamada's Textbook of Gastroenterology (7th ed.), pp. 2178-2180
• Clinical Gastrointestinal Endoscopy (3rd ed.), pp. 841-842
• Maingot's Abdominal Operations, pp. 1041-1042
• Srinu et al. (2024). Short vs. conventional antibiotic duration in cholangitis. Am J Gastroenterol. PMID 37732816 - RCT supporting 4-day courses post-drainage

Differential Diagnosis of Acute Cholangitis

Primary Biliary/Hepatic Differentials

1. Acute Cholecystitis

2. Choledocholithiasis (without cholangitis)

3. Mirizzi's Syndrome

4. Gallstone Pancreatitis

• Caused by a stone transiently obstructing the ampulla; pancreatic inflammation persists even after stone passage
• Shares RUQ/epigastric pain and fever with cholangitis
• Key distinguishing features:
  • Markedly elevated serum amylase/lipase (>3x ULN)
  • Pain typically radiates to the back
  • Jaundice is less prominent and transient
  • Imaging: peripancreatic inflammation on CT, not bile duct dilatation
• Note: when cholangitis and pancreatitis coexist, urgent ERCP is indicated (Yamada's Textbook of Gastroenterology)

5. Pyogenic Liver Abscess

• Presents with fever, RUQ pain, and sometimes jaundice (if biliary involvement)
• Usually more insidious onset with higher, spiking/hectic fevers and diaphoresis
• Jaundice may be absent or mild unless associated with biliary obstruction
• US/CT: hypoechoic or low-density lesion with peripheral ring enhancement - distinguishes it from cholangitis (which shows bile duct changes, not a focal lesion)
• Blood cultures and aspirate culture are the key workup
• Can be a complication of untreated cholangitis (Yamada's Textbook of Gastroenterology)

6. Amebic Liver Abscess

• Fever, RUQ pain; history of travel to or residence in endemic area
• More common in young men
• Serological test for Entamoeba histolytica antibodies is positive in >90%
• Aspirate has characteristic "anchovy paste" appearance (necrotic hepatocytes)
• Single abscess more common than pyogenic (multiple abscesses)
• Jaundice is typically absent (Yamada's Textbook of Gastroenterology)

7. Acute Viral Hepatitis (A, B, E)

• Fever, RUQ pain, jaundice can all be present - can closely mimic cholangitis
• Key distinguishing features:
  • Markedly elevated transaminases (ALT/AST in hundreds to thousands) - disproportionate to ALP/GGT
  • Bile duct dilatation is absent on imaging
  • History of exposure, prodrome of malaise/anorexia/nausea
  • Viral serology (anti-HAV IgM, HBsAg, anti-HEV IgM) confirms diagnosis
• In acute hepatic failure: encephalopathy + coagulopathy + jaundice should prompt evaluation for fulminant hepatitis (Rosen's Emergency Medicine)

Extra-Biliary Differentials

8. Peptic Ulcer Disease / Perforated Ulcer

• Epigastric pain radiating to right; can present with fever if perforation occurs
• Perforated PUD: peritonism (board-like rigidity, absent bowel sounds), free air under diaphragm on erect CXR
• Jaundice is absent
• Amylase may be mildly elevated (from gastric leak)

9. Right Lower Lobe Pneumonia / Pleurisy

• Fever + right-sided upper abdominal pain referred from the diaphragm
• No jaundice
• Cough, pleuritic chest pain, reduced air entry on auscultation
• CXR/CT chest confirms consolidation (Current Surgical Therapy, 14e)

10. Empyema (Right-sided)

• Fever + pleuritic right-sided pain; can be confused if referred abdominally
• No jaundice; no biliary changes on imaging (Current Surgical Therapy, 14e)

11. Appendicitis (Atypical/Retrocecal)

• Occasionally presents with RUQ pain (retrocecal or subhepatic appendix)
• Fever and leukocytosis present
• No jaundice; no bile duct changes
• CT abdomen is diagnostic

12. Life-threatening Diagnoses Not to Miss

Diagnostic Approach Summary

Tokyo Guidelines (TG18): Classification of Acute Cholangitis

Part 1 - Diagnostic Criteria (TG18)

• Suspected cholangitis: 1 criterion from A + 1 criterion from B or C
• Definite cholangitis: 1 criterion from A + 1 from B + 1 from C

Part 2 - Severity Grading (TG18)

Grade I - Mild Cholangitis

• Does not meet criteria for Grade II or Grade III at initial presentation
• No organ dysfunction
• Responds to initial medical treatment (IV antibiotics + fluids)

Grade II - Moderate Cholangitis

Grade III - Severe Cholangitis

Part 3 - Treatment Based on Grade (TG18)

Specific triggers for urgent biliary drainage (<24 hours):

1. Severe (Grade III) cholangitis - regardless of aetiology
2. Obstructive biliary stones with moderate (Grade II) or severe (Grade III) cholangitis
3. Mild (Grade I) cholangitis not responding to IV antibiotics and fluid resuscitation

Summary Diagram

CHOLANGITIS SUSPECTED
        |
  TG18 Diagnostic Criteria Met?
        |
   YES --> Grade Assessment
        |
  ┌─────┴──────────────────┐
Grade I              Grade II           Grade III
(Mild)              (Moderate)          (Severe)
No organ         ≥2 lab/clinical      ≥1 organ failure
dysfunction       criteria met
     |                 |                    |
IV Abx + IVF    Early ERCP          ICU + Stabilise
 <72h ERCP      ± Urgent if          + URGENT ERCP
 if responds    stones/no response     <24 hours

Key Points

• Grade determines urgency, not just severity of symptoms - an elderly patient (≥75) with bilirubin ≥5 and fever ≥39°C automatically qualifies as Grade II even without shock
• Reynolds' pentad (hypotension + altered mental status added to Charcot's triad) is the clinical correlate of Grade III - mortality approaches 100% without prompt treatment
• CA19-9 may be falsely elevated with biliary obstruction - do not interpret as evidence of malignancy until obstruction resolves
• The TG18 update refined earlier TG13 criteria by clarifying that Grade III triggers are organ system dysfunctions, not just clinical signs of shock